Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
MyoKardia, Inc.
John A Spertus; Jennifer T Fine; Perry Elliott; Carolyn Y Ho; Iacopo Olivotto; Sara Saberi; Wanying Li; Chantal Dolan; Matthew Reaney; Amy J Sehnert; Daniel Jacoby